Wechselwirkungen von Cefoxitin
Cefoxitin (Mefoxin), ein Cephalosporin, hat in den von uns erfassten FDA-Fachinformationen und Faktenblättern 63 dokumentierte Wechselwirkungen: 27 schwerwiegende, 35 mittelschwere, 1 geringfügige und 0, bei denen eine Fachinformation keine relevante Wechselwirkung berichtet. Jeder Eintrag unten zitiert den Satz, auf dem er beruht. Diese Medikamentenseite ist ein Ausgangspunkt, kein Urteil über Ihre persönliche Situation.
Wechselwirkungen laut Fachinformation
Schwerwiegende Wechselwirkungen (27)
Hypersensitivity to cefoxitin or other beta-lactam antibacterial drugs. (Fachinformation zu Cefoxitin, Gegenanzeigen)
Hypersensitivity to cefoxitin or other beta-lactam antibacterial drugs. (Fachinformation zu Cefoxitin, Gegenanzeigen)
Hypersensitivity to cefoxitin or other beta-lactam antibacterial drugs. (Fachinformation zu Cefoxitin, Gegenanzeigen)
Hypersensitivity to cefoxitin or other beta-lactam antibacterial drugs. (Fachinformation zu Cefoxitin, Gegenanzeigen)
Hypersensitivity to cefoxitin or other beta-lactam antibacterial drugs. (Fachinformation zu Cefoxitin, Gegenanzeigen)
Hypersensitivity to cefoxitin or other beta-lactam antibacterial drugs. (Fachinformation zu Cefoxitin, Gegenanzeigen)
Hypersensitivity to cefoxitin or other beta-lactam antibacterial drugs. (Fachinformation zu Cefoxitin, Gegenanzeigen)
Hypersensitivity to cefoxitin or other beta-lactam antibacterial drugs. (Fachinformation zu Cefoxitin, Gegenanzeigen)
Hypersensitivity to cefoxitin or other beta-lactam antibacterial drugs. (Fachinformation zu Cefoxitin, Gegenanzeigen)
Hypersensitivity to cefoxitin or other beta-lactam antibacterial drugs. (Fachinformation zu Cefoxitin, Gegenanzeigen)
Hypersensitivity to cefoxitin or other beta-lactam antibacterial drugs. (Fachinformation zu Cefoxitin, Gegenanzeigen)
Hypersensitivity to cefoxitin or other beta-lactam antibacterial drugs. (Fachinformation zu Cefoxitin, Gegenanzeigen)
Hypersensitivity to cefoxitin or other beta-lactam antibacterial drugs. (Fachinformation zu Cefoxitin, Gegenanzeigen)
Hypersensitivity to cefoxitin or other beta-lactam antibacterial drugs. (Fachinformation zu Cefoxitin, Gegenanzeigen)
Hypersensitivity to cefoxitin or other beta-lactam antibacterial drugs. (Fachinformation zu Cefoxitin, Gegenanzeigen)
Hypersensitivity to cefoxitin or other beta-lactam antibacterial drugs. (Fachinformation zu Cefoxitin, Gegenanzeigen)
Hypersensitivity to cefoxitin or other beta-lactam antibacterial drugs. (Fachinformation zu Cefoxitin, Gegenanzeigen)
Hypersensitivity to cefoxitin or other beta-lactam antibacterial drugs. (Fachinformation zu Cefoxitin, Gegenanzeigen)
Hypersensitivity to cefoxitin or other beta-lactam antibacterial drugs. (Fachinformation zu Cefoxitin, Gegenanzeigen)
Hypersensitivity to cefoxitin or other beta-lactam antibacterial drugs. (Fachinformation zu Cefoxitin, Gegenanzeigen)
Hypersensitivity to cefoxitin or other beta-lactam antibacterial drugs. (Fachinformation zu Cefoxitin, Gegenanzeigen)
INVANZ is contraindicated in patients with known hypersensitivity to any component of this product or to other drugs in the same class or in patients who have demonstrated anaphylactic reactions to beta-lactams. (Fachinformation zu Ertapenem, Gegenanzeigen)
Hypersensitivity Reactions: Serious and occasionally fatal hypersensitivity (anaphylactic) reactions have been reported in patients receiving therapy with beta-lactams. (Fachinformation zu Imipenem und Cilastatin, Warnhinweise und Vorsichtsmaßnahmen)
Hypersensitivity to cefoxitin or other beta-lactam antibacterial drugs. (Fachinformation zu Cefoxitin, Gegenanzeigen)
Hypersensitivity to cefoxitin or other beta-lactam antibacterial drugs. (Fachinformation zu Cefoxitin, Gegenanzeigen)
Hypersensitivity to cefoxitin or other beta-lactam antibacterial drugs. (Fachinformation zu Cefoxitin, Gegenanzeigen)
Hypersensitivity to cefoxitin or other beta-lactam antibacterial drugs. (Fachinformation zu Cefoxitin, Gegenanzeigen)
Mittelschwere Wechselwirkungen (35)
Aminoglycosides: Increased potential of nephrotoxicity. (Fachinformation zu Cefoxitin, Arzneimittelwechselwirkungen)
High concentrations of cefoxitin in the urine may interfere with measurement of urinary 17-hydroxy-corticosteroids by the Porter-Silber reaction, and produce false increases of modest degree in the levels reported. (Fachinformation zu Cefoxitin, Warnhinweise und Vorsichtsmaßnahmen)
Use caution when CAYSTON is administered to patients with a known allergic reaction to beta-lactams. (Fachinformation zu Aztreonam, Warnhinweise und Vorsichtsmaßnahmen)
High concentrations of cefoxitin in the urine may interfere with measurement of urinary 17-hydroxy-corticosteroids by the Porter-Silber reaction, and produce false increases of modest degree in the levels reported. (Fachinformation zu Cefoxitin, Warnhinweise und Vorsichtsmaßnahmen)
High concentrations of cefoxitin in the urine may interfere with measurement of urinary 17-hydroxy-corticosteroids by the Porter-Silber reaction, and produce false increases of modest degree in the levels reported. (Fachinformation zu Cefoxitin, Warnhinweise und Vorsichtsmaßnahmen)
High concentrations of cefoxitin in the urine may interfere with measurement of urinary 17-hydroxy-corticosteroids by the Porter-Silber reaction, and produce false increases of modest degree in the levels reported. (Fachinformation zu Cefoxitin, Warnhinweise und Vorsichtsmaßnahmen)
High concentrations of cefoxitin in the urine may interfere with measurement of urinary 17-hydroxy-corticosteroids by the Porter-Silber reaction, and produce false increases of modest degree in the levels reported. (Fachinformation zu Cefoxitin, Warnhinweise und Vorsichtsmaßnahmen)
High concentrations of cefoxitin in the urine may interfere with measurement of urinary 17-hydroxy-corticosteroids by the Porter-Silber reaction, and produce false increases of modest degree in the levels reported. (Fachinformation zu Cefoxitin, Warnhinweise und Vorsichtsmaßnahmen)
High concentrations of cefoxitin in the urine may interfere with measurement of urinary 17-hydroxy-corticosteroids by the Porter-Silber reaction, and produce false increases of modest degree in the levels reported. (Fachinformation zu Cefoxitin, Warnhinweise und Vorsichtsmaßnahmen)
High concentrations of cefoxitin in the urine may interfere with measurement of urinary 17-hydroxy-corticosteroids by the Porter-Silber reaction, and produce false increases of modest degree in the levels reported. (Fachinformation zu Cefoxitin, Warnhinweise und Vorsichtsmaßnahmen)
High concentrations of cefoxitin in the urine may interfere with measurement of urinary 17-hydroxy-corticosteroids by the Porter-Silber reaction, and produce false increases of modest degree in the levels reported. (Fachinformation zu Cefoxitin, Warnhinweise und Vorsichtsmaßnahmen)
High concentrations of cefoxitin in the urine may interfere with measurement of urinary 17-hydroxy-corticosteroids by the Porter-Silber reaction, and produce false increases of modest degree in the levels reported. (Fachinformation zu Cefoxitin, Warnhinweise und Vorsichtsmaßnahmen)
Ethacrynic acid may increase the ototoxic potential of other drugs such as aminoglycoside and some cephalosporin antibiotics. (Fachinformation zu Etacrynsäure, Arzneimittelwechselwirkungen)
High concentrations of cefoxitin in the urine may interfere with measurement of urinary 17-hydroxy-corticosteroids by the Porter-Silber reaction, and produce false increases of modest degree in the levels reported. (Fachinformation zu Cefoxitin, Warnhinweise und Vorsichtsmaßnahmen)
High concentrations of cefoxitin in the urine may interfere with measurement of urinary 17-hydroxy-corticosteroids by the Porter-Silber reaction, and produce false increases of modest degree in the levels reported. (Fachinformation zu Cefoxitin, Warnhinweise und Vorsichtsmaßnahmen)
High concentrations of cefoxitin in the urine may interfere with measurement of urinary 17-hydroxy-corticosteroids by the Porter-Silber reaction, and produce false increases of modest degree in the levels reported. (Fachinformation zu Cefoxitin, Warnhinweise und Vorsichtsmaßnahmen)
High concentrations of cefoxitin in the urine may interfere with measurement of urinary 17-hydroxy-corticosteroids by the Porter-Silber reaction, and produce false increases of modest degree in the levels reported. (Fachinformation zu Cefoxitin, Warnhinweise und Vorsichtsmaßnahmen)
High concentrations of cefoxitin in the urine may interfere with measurement of urinary 17-hydroxy-corticosteroids by the Porter-Silber reaction, and produce false increases of modest degree in the levels reported. (Fachinformation zu Cefoxitin, Warnhinweise und Vorsichtsmaßnahmen)
Cephalosporin Furosemide can increase the risk of cephalosporin-induced nephrotoxicity even in the setting of minor or transient renal impairment. (Fachinformation zu Furosemid, Arzneimittelwechselwirkungen)
Aminoglycosides: Increased potential of nephrotoxicity. (Fachinformation zu Cefoxitin, Arzneimittelwechselwirkungen)
High concentrations of cefoxitin in the urine may interfere with measurement of urinary 17-hydroxy-corticosteroids by the Porter-Silber reaction, and produce false increases of modest degree in the levels reported. (Fachinformation zu Cefoxitin, Warnhinweise und Vorsichtsmaßnahmen)
High concentrations of cefoxitin in the urine may interfere with measurement of urinary 17-hydroxy-corticosteroids by the Porter-Silber reaction, and produce false increases of modest degree in the levels reported. (Fachinformation zu Cefoxitin, Warnhinweise und Vorsichtsmaßnahmen)
High concentrations of cefoxitin in the urine may interfere with measurement of urinary 17-hydroxy-corticosteroids by the Porter-Silber reaction, and produce false increases of modest degree in the levels reported. (Fachinformation zu Cefoxitin, Warnhinweise und Vorsichtsmaßnahmen)
High concentrations of cefoxitin in the urine may interfere with measurement of urinary 17-hydroxy-corticosteroids by the Porter-Silber reaction, and produce false increases of modest degree in the levels reported. (Fachinformation zu Cefoxitin, Warnhinweise und Vorsichtsmaßnahmen)
Examples Cyclosporine A, trimethoprim/sulfamethoxazole, bile acid sequestrants (cholestyramine), rifampin as well as aminoglycoside, cephalosporin, fluoroquinolone and penicillin classes of antimicrobials Drugs Modulating Glucuronidation Clinical Impact Concomitant use with drugs inducing glucuronidation decreases MPA systemic exposure, potentially reducing mycophenolate… (Fachinformation zu Mycophenolat, Arzneimittelwechselwirkungen)
Aminoglycosides: Increased potential of nephrotoxicity. (Fachinformation zu Cefoxitin, Arzneimittelwechselwirkungen)
High concentrations of cefoxitin in the urine may interfere with measurement of urinary 17-hydroxy-corticosteroids by the Porter-Silber reaction, and produce false increases of modest degree in the levels reported. (Fachinformation zu Cefoxitin, Warnhinweise und Vorsichtsmaßnahmen)
Aminoglycosides: Increased potential of nephrotoxicity. (Fachinformation zu Cefoxitin, Arzneimittelwechselwirkungen)
High concentrations of cefoxitin in the urine may interfere with measurement of urinary 17-hydroxy-corticosteroids by the Porter-Silber reaction, and produce false increases of modest degree in the levels reported. (Fachinformation zu Cefoxitin, Warnhinweise und Vorsichtsmaßnahmen)
High concentrations of cefoxitin in the urine may interfere with measurement of urinary 17-hydroxy-corticosteroids by the Porter-Silber reaction, and produce false increases of modest degree in the levels reported. (Fachinformation zu Cefoxitin, Warnhinweise und Vorsichtsmaßnahmen)
- ProbenecidMittelschwer
Drug Interactions When probenecid is used to elevate plasma concentrations of penicillin or other beta-lactams, or when such drugs are given to patients taking probenecid therapeutically, high plasma concentrations of the other drug may increase the incidence of adverse reactions associated with that drug. (Fachinformation zu Probenecid, Arzneimittelwechselwirkungen)
- Probenecid und ColchicinMittelschwer
DRUG INTERACTIONS When probenecid is used to elevate plasma concentrations of penicillin, or other beta-lactams, or when such drugs are given to patients taking probenecid therapeutically, high plasma concentrations of the other drug may increase the incidence of adverse reactions associated with that drug. (Fachinformation zu Probenecid und Colchicin, Arzneimittelwechselwirkungen)
- ProtaminMittelschwer
Drug Interactions Protamine sulfate has been shown to be incompatible with certain antibiotics, including several of the cephalosporins and penicillins (see DOSAGE AND ADMINISTRATION ). (Fachinformation zu Protamin, Vorsichtsmaßnahmen)
Aminoglycosides: Increased potential of nephrotoxicity. (Fachinformation zu Cefoxitin, Arzneimittelwechselwirkungen)
High concentrations of cefoxitin in the urine may interfere with measurement of urinary 17-hydroxy-corticosteroids by the Porter-Silber reaction, and produce false increases of modest degree in the levels reported. (Fachinformation zu Cefoxitin, Warnhinweise und Vorsichtsmaßnahmen)
Geringfügige Erwähnungen (1)
Before initiating therapy with Meropenem for injection, it is important to inquire about previous hypersensitivity reactions to penicillins, cephalosporins, other β-lactams, and other allergens. (Fachinformation zu Meropenem, Warnhinweise und Vorsichtsmaßnahmen)
Prüfen Sie Cefoxitin gegen alles, was Sie einnehmen. Fügen Sie Ihre gesamte Liste hinzu; alle Paare werden auf einmal geprüft.
Im Wechselwirkungscheck öffnenKeine medizinische Beratung. Der Schweregrad gibt die Formulierung der Fachinformation wieder, nicht Ihre persönlichen Umstände. Eine als „schwerwiegend“ eingestufte Wechselwirkung kann unter Aufsicht Routine sein, und eine „geringfügige“ kann bei hohen Dosen von Bedeutung sein. Fragen Sie in einer Apotheke nach.